Details of the Drug-Related molecule(s) Expression Atlas

General Information of Drug (ID: DMEXPAU)

Drug Name
N,N-methylenebis-2-phenylacetamide and benzenesulfonamide derivative 1 Drug Info
Synonyms PMID27215781-Compound-38
Indication
Disease Entry ICD 11 Status REF
Osteoporosis FB83.0 Patented [1]
Cross-matching ID
PubChem CID
4296438
ChEBI ID
CHEMBL2179776
TTD Drug ID
DMEXPAU

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Cannabinoid receptor 2 (CB2) TTMSFAW CNR2_HUMAN Not Available [1]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule Molecule Type Gene Name Liver Colon Kidney Small Intestine
Cannabinoid receptor 2 (CB2) DTT CNR2 7.037 6.733 6.944 7.163
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease Osteoporosis
ICD Disease Classification FB83.0
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Cannabinoid receptor 2 (CB2) DTT CNR2 3.82E-02 -0.43 -1.18
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update.Expert Opin Ther Pat. 2016 Jul;26(7):843-56.